Achieve Life Sciences Inc (ACHV) Stock Forecast & Price Target
Achieve Life Sciences Inc · NASDAQ
$6.17-0.01 (-0.16%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Achieve Life Sciences Inc, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $12.00 to $19.00, a moderate spread. The average target of $14.67 sits 138% above the current $6.17. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-0.16 next quarter toward $-0.49 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Achieve Life Sciences Inc.
As of Jul, 3 of 3 firms rate ACHV a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ACHV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.16
Range $-0.26 – $-0.10 · 9 analysts · -43% YoY
Next period, 9 analysts expect Achieve Life Sciences Inc to earn $-0.16 a share (range $-0.26 – $-0.10), versus $-0.28 a year earlier. Full-year consensus is $-0.68, growing to $-0.49 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 9 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $36.9M next year.
Top analysts covering Achieve Life Sciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ACHV.
#1
Jason Butler
JMP Securities · Rank #22
Buy
$19.00+207.9% to target
Overall win rate
57%
+ Follow
#2
Francois Brisebois
Oppenheimer · Rank #186
Buy
$11.00+78.3% to target
Overall win rate
40%
+ Follow
#3
Mark Smith
Lake Street · Rank #326
Buy
$11.00+78.3% to target
Overall win rate
32%
+ Follow
#4
Jason McCarthy
Maxim Group · Rank #360
Buy
$10.00+62.1% to target
Overall win rate
30%
+ Follow
#5
BF
Brandon Folkes
HC Wainwright & Co.
Buy
$12.00+94.5% to target
Coverage
—
+ Follow
ACHV stock forecast FAQ
What is ACHV's average 12-month price target?+
The 3 analysts with a live target average $14.67 for Achieve Life Sciences Inc over the next 12 months, ranging from a $19.00 high to a $12.00 low.
Is ACHV stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ACHV?+
The Street-high target is $19.00 (Citizens), and the Street-low is $12.00 (HC Wainwright & Co.). The average of all 3 active targets is $14.67.
How many Wall Street analysts cover ACHV?+
3 analysts have an active rating on Achieve Life Sciences Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering ACHV?+
Among analysts who currently cover ACHV, Jason Butler of JMP Securities has the strongest overall Quantellect track record (Rank #22). Their current call is Buy with a $19.00 target.
What is Achieve Life Sciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.16 per share (range $-0.26 – $-0.10) across 9 analysts. Full-year EPS is projected at $-0.68, rising to $-0.49 the following year.
How much revenue is Achieve Life Sciences Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $36.9M next year.
Have analysts been upgrading or downgrading ACHV lately?+
As of Jul, 3 of 3 firms rate ACHV a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ACHV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
